Polyvinyl alcohol


Generic Medicine Info
Indications and Dosage
Ophthalmic
Dry eye
Adult: As 1.4% solution: Instill 1-2 drops onto the affected eye(s) as often as necessary.
Child: Same as adult dose.
Special Precautions
Children. Pregnancy and lactation.
Adverse Reactions
Eye disorders: Mild stinging or irritation of the eye, crusting of eyelid, eye pain, ocular hyperaemia, eye pruritus, foreign body sensation, eye discharge, increased lacrimation.
Patient Counseling Information
This drug may cause transient blurring of vision, if affected, do not drive or operate machinery. Remove contact lenses prior to ophthalmic administration and reinsert after 15 min.
Action
Description:
Mechanism of Action: Polyvinyl alcohol, a nonionic surfactant, is used as an ocular lubricant. It protects and lubricates mucous membrane surfaces of the eye thereby relieving dryness and irritation. It also increases the viscosity of the solution and prolongs contact time with the eye.
Storage
Store between 20-25°C. Do not freeze.
MIMS Class
Ophthalmic Lubricants
References
Anon. Artificial Tears. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 22/12/2017.

Artificial Tears Polyvinyl Alcohol Solution/Drops (Akorn, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 21/12/2017.

Buckingham R (ed). Polyvinyl Alcohol. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 22/12/2017.

Joint Formulary Committee. Polyvinyl Alcohol. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 22/12/2017.

Disclaimer: This information is independently developed by MIMS based on Polyvinyl alcohol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in